Drug Pipeline

Tiespectus Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
3
Active Studies
2
Recruiting
2
Phase 3
1
Top Sponsors
2
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-05-29 NCT06664502
A 2-part Study Consisting of a Multiple Ascending Dose Safety Study in Participants With…
date change Primary completion moved earlier: 2026-04-30 -> 2026-03-25
2026-05-29 NCT06664502
A 2-part Study Consisting of a Multiple Ascending Dose Safety Study in Participants With…
date change Completion pushed: 2026-05-31 -> 2026-08-11
Active Studies by Phase
Phase 2/3
2
Phase 1/2
1
Active Trials
NCT IDTitleConditionStatus
Phase 2/3
NCT07440225 A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-002) Macular Degeneration Recruiting
NCT07496567 A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-003) Macular Degeneration Recruiting
Phase 1/2
NCT06664502 A 2-part Study Consisting of a Multiple Ascending Dose Safety Study in Participants With… Diabetic Macular Edema (DME) Active, Not Recruiting
Sponsors Running Tiespectus Trials
Get alerts when Tiespectus trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free